ALI HEALTH released an official statement confirming the composition of its Board of Directors and related committee appointments, effective at the close of business on 11 September 2026.

Key changes and composition details:

1. Board Structure • The Board now consists of seven directors: three Executive Directors, one Non-executive Director and three Independent Non-executive Directors. • Yu Yong has been reaffirmed as both Chairman and Chief Executive Officer, underscoring continuity in executive leadership.

2. Committee Leadership • Audit Committee: Chaired by Independent Non-executive Director Wu May Yihong. • Nomination Committee: Chaired by Independent Non-executive Director Huang Yi Fei (Vanessa). • Remuneration Committee: Chaired by Executive Director Yu Yong.

3. Committee Memberships • Non-executive Director Huang Jiaojiao joins the Audit Committee. • Independent Non-executive Directors Shao Rong and Huang Yi Fei (Vanessa) serve on both the Audit and Nomination Committees. • Wu May Yihong sits on all three committees, providing cross-functional oversight.

The updated governance framework signals ALI HEALTH’s commitment to balanced representation and strengthened oversight across key board committees.